已收录 272814 条政策
 政策提纲
  • 暂无提纲
Expression of Human Epidermal Growth Factor Receptor 2/Neu in Oral Leukoplakia
[摘要] Background:  Molecular alterations in premalignant lesions of the oral cavity are not well known. Many reports have found increased human epidermal growth factor receptor 2 (HER-2) expression in oral cancer. Overexpression of HER-2 in premalignant lesions may denote its positive contribution in the malignant transformation of these lesions. Materials and Methods:  Twenty-three samples of leukoplakia were stained by routine H and E to assess any dysplasia; five samples of normal mucosa were used as control. Immunohistochemical staining for HER-2 was done. ASCO/CAP 2018 guidelines were used for reporting the results. The percentage of lesions expressing cytoplasmic or membranous expression was calculated. Results:  One sample of leukoplakia with severe dysplasia expressed focal membranous staining. Cytoplasmic staining was observed in 3/9 (33.33%) dysplastic leukoplakia. Only one nondysplastic leukoplakia expressed cytoplasmic HER-2 staining. Conclusions:  Membranous expression in severe dysplasia and higher expression in oral cancer are in concordance with the multistep theory of carcinogenesis.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 皮肤病学
[关键词] Dysplasia;human epidermal growth factor receptor 2;leukoplakia;premalignant [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文